Home
/
iBio, Inc.
/
Financials
/
Quarterly
iBio, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that iBio, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Mar 31, 2024
$50.0K
May 13, 2024
Q2
2024
Dec 31, 2023
$50.0K
Feb 9, 2024
Q1
2024
Sep 30, 2023
$50.0K
Nov 14, 2023
Q3
2023
Mar 31, 2023
$0
May 15, 2023
Q2
2023
Dec 31, 2022
$0
May 19, 2023
Q1
2023
Sep 30, 2022
$0
Nov 14, 2022
Q3
2023
Mar 31, 2022
$1.80M
May 15, 2023
Q2
2023
Dec 31, 2021
$0
May 19, 2023
Q1
2023
Sep 30, 2021
$84.0K
Nov 14, 2022
Q3
2022
Mar 31, 2021
$765.0K
May 12, 2022
Q2
2022
Dec 31, 2020
$705.0K
Feb 14, 2022
Q1
2022
Sep 30, 2020
$410.0K
Nov 15, 2021
Q3
2021
Mar 31, 2020
$96.0K
May 17, 2021
Q2
2021
Dec 31, 2019
$314.0K
Feb 16, 2021
Q1
2021
Sep 30, 2019
$108.0K
Nov 16, 2020
Q3
2020
Mar 31, 2019
$527.0K
May 15, 2020
Q2
2020
Dec 31, 2018
$651.0K
Feb 14, 2020
Q1
2020
Sep 30, 2018
$45.0K
Nov 14, 2019
Q3
2019
Mar 31, 2018
$78.0K
May 10, 2019
Q2
2019
Dec 31, 2017
$153.0K
Feb 13, 2019
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
$0
Feb 10, 2026
Q1
2026
Sep 30, 2025
$100.0K
Nov 17, 2025
Q3
2025
Mar 31, 2025
$0
May 2, 2025
Q2
2026
Dec 31, 2024
$200.0K
Feb 10, 2026
Q1
2026
Sep 30, 2024
$0
Nov 17, 2025
Q3
2025
Mar 31, 2024
$50.0K
May 2, 2025
Q2
2025
Dec 31, 2023
$50.0K
Feb 10, 2025
Q1
2025
Sep 30, 2023
$50.0K
Nov 12, 2024
Q2
2024
Jun 30, 2023
$0
Feb 9, 2024
Q3
2024
Jun 30, 2023
$0
May 13, 2024
Q1
2024
Sep 30, 2022
$0
Nov 14, 2023
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2018
Mar 31, 2018
$78.0K
May 11, 2018
Q2
2018
Dec 31, 2017
$153.0K
Feb 14, 2018
Q1
2018
Sep 30, 2017
$122.0K
Nov 9, 2017
Q3
2018
Mar 31, 2017
$37.0K
May 11, 2018
Q2
2018
Dec 31, 2016
$75.0K
Feb 14, 2018
Q1
2018
Sep 30, 2016
$135.0K
Nov 9, 2017
Q3
2017
Mar 31, 2016
$379.0K
May 15, 2017
Q2
2017
Dec 31, 2015
$134.0K
Feb 21, 2017
Q1
2017
Sep 30, 2015
$160.0K
Nov 18, 2016
Q3
2016
Mar 31, 2015
$349.0K
May 23, 2016
Q2
2016
Dec 31, 2014
$367.0K
Feb 22, 2016
Q1
2016
Sep 30, 2014
$819.0K
Nov 13, 2015
Q3
2015
Mar 31, 2014
$0
May 15, 2015
Q2
2015
Dec 31, 2013
$0
Feb 24, 2015
Q1
2015
Sep 30, 2013
$0
Nov 14, 2014
Q3
2014
Mar 31, 2013
$0
May 15, 2014
Q2
2014
Dec 31, 2012
$0
Feb 14, 2014
Q1
2014
Sep 30, 2012
$390.0K
Nov 14, 2013
Q3
2013
Mar 31, 2012
$371.8K
May 20, 2013
Q2
2013
Dec 31, 2011
$233.8K
Feb 19, 2013
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
($8.99M)
Feb 10, 2026
Q2
2026
Sep 30, 2025
($5.72M)
Feb 10, 2026
Q1
2026
Sep 30, 2025
($5.72M)
Nov 17, 2025
Q3
2025
Mar 31, 2025
($4.86M)
May 2, 2025
Q2
2026
Dec 31, 2024
($4.36M)
Feb 10, 2026
Q3
2025
Dec 31, 2024
($4.36M)
May 2, 2025
Q3
2025
Sep 30, 2024
($3.99M)
May 2, 2025
Q1
2026
Sep 30, 2024
($3.99M)
Nov 17, 2025
Q2
2026
Sep 30, 2024
($3.99M)
Feb 10, 2026
Q3
2025
Mar 31, 2024
($3.17M)
May 2, 2025
Q2
2025
Dec 31, 2023
($8.21M)
Feb 10, 2025
Q3
2025
Dec 31, 2023
($8.21M)
May 2, 2025
Q1
2025
Sep 30, 2023
($5.75M)
Nov 12, 2024
Q2
2025
Sep 30, 2023
($5.75M)
Feb 10, 2025
Q3
2025
Sep 30, 2023
($5.75M)
May 2, 2025
Q3
2023
Mar 31, 2023
($7.29M)
May 15, 2023
Q3
2023
Dec 31, 2022
($33.55M)
May 15, 2023
Q2
2023
Dec 31, 2022
($33.55M)
May 19, 2023
Q3
2023
Sep 30, 2022
($18.13M)
May 15, 2023
Q2
2023
Sep 30, 2022
($18.13M)
May 19, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
($9.45M)
Feb 10, 2026
Q1
2026
Sep 30, 2025
($5.95M)
Nov 17, 2025
Q3
2025
Mar 31, 2025
($4.88M)
May 2, 2025
Q2
2026
Dec 31, 2024
($4.42M)
Feb 10, 2026
Q1
2026
Sep 30, 2024
($4.11M)
Nov 17, 2025
Q3
2025
Mar 31, 2024
($3.63M)
May 2, 2025
Q2
2025
Dec 31, 2023
($4.50M)
Feb 10, 2025
Q1
2025
Sep 30, 2023
($5.10M)
Nov 12, 2024
Q3
2024
Mar 31, 2023
($6.17M)
May 13, 2024
Q2
2024
Dec 31, 2022
($10.57M)
Feb 9, 2024
Q1
2024
Sep 30, 2022
($7.64M)
Nov 14, 2023
Q3
2023
Mar 31, 2022
($6.79M)
May 15, 2023
Q2
2023
Dec 31, 2021
($7.23M)
May 19, 2023
Q1
2023
Sep 30, 2021
($5.23M)
Nov 14, 2022
Q3
2022
Mar 31, 2021
($7.20M)
May 12, 2022
Q2
2022
Dec 31, 2020
($7.55M)
Feb 14, 2022
Q1
2022
Sep 30, 2020
($6.92M)
Nov 15, 2021
Q3
2021
Mar 31, 2020
($4.06M)
May 17, 2021
Q2
2021
Dec 31, 2019
($3.16M)
Feb 16, 2021
Q1
2021
Sep 30, 2019
($3.86M)
Nov 16, 2020